AI assistant
Ocugen, Inc. — Director's Dealing 2021
Jun 17, 2021
32915_dirs_2021-06-17_126fab63-ae79-43ee-88d7-51814e4942dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-06-15
Reporting Person: Subramanian Sanjay (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-15 | Common Stock | M | 31000 | $0.34 | Acquired | 76591 | Direct |
| 2021-06-15 | Common Stock | S | 31000 | $7 | Disposed | 45591 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-15 | Option (Right to Buy) | $0.34 | M | 31000 | Disposed | 2030-05-05 | Common Stock (31000) | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $6.96 to $7.07, inclusive.
F3: The option, initially representing a right to purchase a total of 369,256 shares, vests and becomes exercisable in equal annual installments over a three year period, commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates.